Novo Integrated Sciences(OTC) NVOS

Market Cap$11.80K

Since IPO (2017)-100%

5 Year-100%

1 Year+20%

1 Month-85%

$0.00

-72.73%

-0.00Today

Novo Integrated Sciences last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-20

Novo Integrated Sciences stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-73.33%	USD 0.00	2026-08-13
1 month	-85%	USD 0.00	2026-07-21
3 month	-82.86%	USD 0.00	2026-05-22
Year to date	-77.78%	USD 0.00	2025-12-31
1 year	+20%	USD 0.00	2025-08-20
3 year	-99.97%	USD 1.78	2023-08-21
5 year	-100%	USD 17.00	2021-08-20
Since inception	-100%	USD 84.00	2017-05-10

Novo Integrated Sciences Financials at a Glance

Market Cap

$11.80K

Revenue (TTM)

$13.29M

Net Income (TTM)

-$16.17M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-8.45 (Low)

Dividend

$0.00

Beta (Volatility)

-8.45 (Low)

Price

$0.00

Volume

1,200

Open

$0.00

Price

$0.00

Volume

1,200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.06

Estimated Earnings Date

Jul 21, 2025

Dividend

$0.00

Beta (Volatility)

-8.45 (Low)

Price

$0.00

Volume

1,200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.06

Estimated Earnings Date

Jul 21, 2025

NVOS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novo Integrated Sciences

Novo Integrated Sciences, Inc. is a healthcare company that provides a wide range of primary healthcare services and products. The company operates through two main segments: Healthcare Services and Product Manufacturing and Development, focusing on innovative therapeutic approaches for various health conditions.

Products and Services

Comprehensive healthcare services including physiotherapy, chiropractic care, and occupational therapy
Specialized treatments such as acupuncture, functional dry needling, and advanced rehabilitation
Development and distribution of bespoke health and wellness product solutions

Growth Outlook

Recent quarterly revenue reached approximately $3.08 million, indicating strong service demand
Gross profit margin improved to 51.2% in the latest quarter, showcasing operational efficiency
Expansion plans include increasing the number of clinics to enhance service accessibility

Financial Highlights

Trailing twelve months revenue totaled approximately $12.5 million, reflecting consistent growth
Net income for the latest quarter was $5.0 million, a significant turnaround from previous losses
Cash and cash equivalents stood at $844,584, providing liquidity for operational needs

Novo Integrated Sciences, Inc. is positioned in the healthcare sector, focusing on delivering high-quality services across various demographics. The company has demonstrated a commitment to improving patient outcomes through innovative treatment options and a robust service portfolio. Recent financial performance indicates a positive trajectory, with increasing revenues and improved profit margins. The strategic expansion of clinic locations aims to further enhance service delivery and accessibility, making Novo Integrated Sciences an intriguing option for potential investors interested in the healthcare industry.

AI Generated • Aug 10, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

264

CEO

Robert Mattacchione

Website

novointegrated.com

Headquarters

Bellevue, WA 98004, US

NVOS Financials

Key Financial Metrics (TTM)

Gross Margin

43.20%

Operating Margin

-62.54%

Net Income Margin

-121.32%

Return on Equity

-81.23%

Return on Capital

-42.41%

Return on Assets

-50.18%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.80K

Shares Outstanding

19.73M

Volume

1.20K

Avg. Volume

4.08K

Financials (TTM)

Gross Profit

$5.74M

Operating Income

-$8.31M

EBITDA

-$6.64M

Operating Cash Flow

-$5.07M

Capital Expenditure

-$5.04K

Free Cash Flow

-$5.07M

Cash & ST Invst.

$844.58K

Total Debt

$4.71M

Novo Integrated Sciences Performance Analysis

Novo Integrated Sciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-08-31	USD 9,305,255	N/A
2022	2022-08-31	USD 11,737,937	26.1%
2023	2023-08-31	USD 12,572,019	7.1%
2024	2024-08-31	USD 13,294,357	5.7%

Novo Integrated Sciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2023-11-30	17.8%
Q2	2024-02-29	-18.5%
Q3	2024-05-31	-0.6%
Q4	2024-08-31	-2.3%

Novo Integrated Sciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-08-31	USD -1.80	N/A
2022	2022-08-31	USD -11.28	526.3%
2023	2023-08-31	USD -1.30	-88.5%
2024	2024-08-31	USD -0.90	-31.0%

Novo Integrated Sciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2023-11-30	-40.0%
Q2	2024-02-29	42.9%
Q3	2024-05-31	-362.5%
Q4	2024-08-31	135.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2024YOY CHG

Revenue

$3.08M

-6.7%

Gross Profit

$1.58M

+70.0%

Gross Margin

51.21%

N/A

Market Cap

$11.80K

N/A

Market Cap/Employee

$102.61

N/A

Employees

115

N/A

Net Income

$5.00M

+258.3%

EBITDA

$7.25M

+440.7%

Quarterly Fundamentals

Name

Q4 2024YOY CHG

Total Cash

$844.58K

+102.9%

Total Debt

$4.71M

+5.3%

Accounts Receivable

$3.15M

+114.9%

Inventory

$1.00M

-9.6%

Long Term Debt

$2.99M

+70.2%

Short Term Debt

$3.16M

+16.4%

Return on Assets

-50.18%

N/A

Return on Invested Capital

-47.34%

N/A

Free Cash Flow

-$548.95K

-111.8%

Operating Cash Flow

-$545.92K

-138.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ACGIThe Amacore Group, Inc.

ACGIThe Amacore Group, Inc.$0.00+0.00%

ADVTAdvantis Corp.

ADVTAdvantis Corp.$0.00+0.00%

PBLAPanbela Therapeutics, Inc.

PBLAPanbela Therapeutics, Inc.$0.00+9900.00%

BRAXFBraxia Scientific Corp.

BRAXFBraxia Scientific Corp.$0.00+0.00%

OMHEOMNI Health, Inc.

OMHEOMNI Health, Inc.$0.00+0.00%

SETOSETO Holdings, Inc.

SETOSETO Holdings, Inc.$0.01+0.00%

JNHMFJack Nathan Medical Corp.

JNHMFJack Nathan Medical Corp.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$41.20+0.06%

MSTRStrategy

MSTRStrategy$112.39+0.08%

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF$46.25-0.02%

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF$122.21+0.01%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$17.55+0.11%

BMNRBitmine Immersion Technologies

BMNRBitmine Immersion Technologies$21.57+0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$70.48-0.02%

Questions About NVOS

What is the current price of Novo Integrated Sciences?

Novo Integrated Sciences is trading at $0.00 per share.

What is the 52-week range for Novo Integrated Sciences?

Over the past 52 weeks, Novo Integrated Sciences has traded between $0.00 and $0.06.

How much debt does Novo Integrated Sciences have?

As of the most recent reporting period, Novo Integrated Sciences reported total debt of $5.98M.

How much cash does Novo Integrated Sciences have on hand?

Novo Integrated Sciences reported $844.58K in cash and cash equivalents in its most recent financial results.

What is Novo Integrated Sciences’s dividend yield?

Novo Integrated Sciences does not currently have a dividend yield.

Novo Integrated Sciences(OTC) NVOS

Novo Integrated Sciences Financials at a Glance

NVOS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Novo Integrated Sciences

NVOS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Novo Integrated Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NVOS

What is the current price of Novo Integrated Sciences?

What is the 52-week range for Novo Integrated Sciences?

How much debt does Novo Integrated Sciences have?

How much cash does Novo Integrated Sciences have on hand?

What is Novo Integrated Sciences’s dividend yield?

Premium Investing Services